U.S. stock futures showed slight gains in early evening trading as investors looked for stability following a volatile period. The S&P 500 rose by 0.4%, the Nasdaq 100 increased by 0.5%, and the Dow Industrials also ticked higher by 0.4%. This uptick comes after markets experienced a sharp drop, partially offsetting the gains from the previous day spurred by the White House's temporary halt on 90-day reciprocal tariffs for non-Chinese trading partners.
Concerns over a potential global recession persist, exacerbated by ongoing tariffs on Chinese imports, keeping the VIX volatility index above 50. Further tension arises from reports suggesting the Trump administration is contemplating the delisting of Chinese companies from U.S. stock exchanges, indicating a sustained standoff with Beijing.
In other market developments, commodity prices were relatively stable with WTI crude oil prices remaining just above $60 per barrel, while gold futures reached new heights, exceeding $3,200 per ounce.
On Wall Street, certain stocks made significant moves. Forge Global Holdings (FRGE) surged 10.4% after a Q1 revenue announcement. Argenx SE (ARGX, Financial) saw an 8.8% increase following FDA approval for a new self-injection option of its product Vyvgart. TreeHouse Foods (THS) rose 5.0% after pre-announcing Q1 revenue, and Charles River Laboratories (CRL) climbed 4.0% as it recovers from a prior 28% decline due to the FDA's decision to phase out animal testing for monoclonal antibodies.
Harley-Davidson (HOG) shares increased by 3.6% following a Bloomberg report that the company is considering selling its financing arm, valued over $1 billion. In contrast, Logitech International S.A. (LOGI) fell by 0.7% after it withdrew its guidance for fiscal year 2026.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 24 analysts, the average target price for argenx SE (ARGX, Financial) is $726.52 with a high estimate of $1,100.00 and a low estimate of $416.00. The average target implies an upside of 33.09% from the current price of $545.89. More detailed estimate data can be found on the argenx SE (ARGX) Forecast page.
Based on the consensus recommendation from 25 brokerage firms, argenx SE's (ARGX, Financial) average brokerage recommendation is currently 1.6, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for argenx SE (ARGX, Financial) in one year is $2054.21, suggesting a upside of 276.3% from the current price of $545.89. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the argenx SE (ARGX) Summary page.
